In 2010 AstraZeneca launched the Young Health Programme (YHP) to improve the health and life chances of young people in some of the most under‑resourced communities around the world. Since then, the YHP has reached more than five million youth in dozens of countries and has been recognised both for its award-winning approach and for bringing a greater focus on the issue of disease prevention and youth health into global, national and local discourse.
In 2020, we:
- Launched 6 new YHP country programmes
- Reached 1 million youth directly
- Trained 55k peer educators and health professionals
- Incorporated advocacy into 11 country programmes
- Had over 1,300 AstraZeneca volunteers engaged in YHP events
- Funded 2 major research projects
- Awarded 20 One Young World Scholarships and 20 Step Up! grants to young health innovators
The YHP aims to address the growing global burden of non-communicable diseases (NCDs) such as heart disease, diabetes, cancers or respiratory diseases through primary prevention. It promotes education and awareness of the primary NCD risk factors to youth aged 10 to 24 so that young people can make informed choices and protect their health in the future.
The World Health Organisation estimates that 70% of premature deaths among adults are largely due to behaviour initiated during adolescence.1
We renewed our commitment to the YHP in 2019 with a pledge of $35m to continue the programme through 2025. Working with our partners, we hope to reach a further ten million young people over the next five years, helping them to make better health choices for brighter life chances.
1. WHO Department of Child and Adolescent Health and Development, Improving Adolescent Health and Development. Available at https://apps.who.int/iris/bitstream/handle/10665/64320/WHO_FRH_ADH_98.18_Rev.1.pdf accessed January 2021